Involvement of the CA1 GABAA receptors in ACPA-induced impairment of spatial and non-spatial novelty detection in mice

Neurobiology of Learning and Memory

Volumn 100, Issue , 2013, Pages 32-40

  Yousefi, Behnam ^a   Farjad, Meisam ^b   Nasehi, Mohammad ^c   Zarrindast, Mohammad Reza ^d,e,f,g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^g INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

Author keywords

ACPA; Bicuculline; Hippocampus (CA1); Mice; Muscimol; Spatial and non spatial memory

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; CANNABINOID 1 RECEPTOR AGONIST; MUSCIMOL; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYLCYCLOPROPYLAMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; LEARNING; LOCOMOTION; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MENTAL TASK; MOUSE; NONHUMAN; OPEN FIELD TEST; PROTEIN FUNCTION; SPATIAL MEMORY; STIMULUS RESPONSE; ANIMAL; BEHAVIOR; DRUG EFFECT; MEMORY; METABOLISM; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BICUCULLINE; CA1 REGION, HIPPOCAMPAL; GABA-A RECEPTOR AGONISTS; GABA-A RECEPTOR ANTAGONISTS; MALE; MEMORY; MICE; MUSCIMOL; RECEPTORS, GABA-A; SPATIAL BEHAVIOR;

MLCS; MLOWN;

EID: 84871847013     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2012.12.001     Document Type: Article

References (113)

1. Adriani W., Sargolini F., Coccurello R., Oliverio A., Mele A. Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice. Psychopharmacology (Berlin) 2000, 150:67-76.
2. Akirav I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Frontiers in Behavioral Neuroscience 2011, 5:34.
3. Alger B.E., Nicoll R.A. Pharmacological evidence for two kinds of GABA receptor on rat hippocampal pyramidal cells studied in vitro. Journal of Physiology 1982, 328:125-141.
4. Alger B.E., Pitler T.A. Retrograde signaling at GABAA-receptor synapses in the mammalian CNS. Trends in Neurosciences 1995, 18:333-340.
5. Ameri A. The effects of cannabinoids on the brain. Progress in Neurobiology 1999, 58:315-348.
6. Ashton C.H., Moore P.B. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatrica Scand. 2011, 124:250-261.
7. Bambico F.R., Duranti A., Tontini A., Tarzia G., Gobbi G. Endocannabinoids in the treatment of mood disorders: Evidence from animal models. Current Pharmaceutical Design 2009, 15:1623-1646.
8. Bliss T.V., Collingridge G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
9. Brown M.W., Barker G.R., Aggleton J.P., Warburton E.C. What pharmacological interventions indicate concerning the role of the perirhinal cortex in recognition memory. Neuropsychologia 2012, 50:3122-3140.
10. Brusco A., Tagliaferro P., Saez T., Onaivi E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse (New York, N. Y.) 2008, 62:944-949.
11. Burgdorf J.R., Kilmer B., Pacula R.L. Heterogeneity in the composition of marijuana seized in California. Drug and Alcohol Dependence 2011, 117:59-61.
12. Burns T.L., Ineck J.R. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. Annals of Pharmacotherapy 2006, 40:251-260.
13. Buzsaki G. Functions for interneuronal nets in the hippocampus. Canadian Journal of Physiology and Pharmacology 1997, 75:508-515.
14. Carlson G., Wang Y., Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nature Neuroscience 2002, 5:723-724.
15. Cobb S.R., Buhl E.H., Halasy K., Paulsen O., Somogyi P. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 1995, 378:75-78.
16. Da S., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002, 26:321-325.
17. Davies S.N., Pertwee R.G., Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 2002, 42:993-1007.
18. de Oliveira Alvares L., de Oliveira L.F., Camboim C., Diehl F., Genro B.P., Lanziotti V.B., et al. Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats. Neurobiology of Learning and Memory 2005, 83:119-124.
19. De Oliveira Alvares L., Genro B.P., Vaz Breda R., Pedroso M.F., Da Costa J.C., Quillfeldt J.A., et al. AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats. Brain Research. Developmental Brain Research 2006, 1075:60-67.
20. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
21. Di Marzo V., Bifulco M., De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nature Reviews Drug Discovery Review 2004, 3:771-784.
22. Egashira N., Manome N., Mishima K., Iwasaki K., Oishi R., Fujiwara M. Involvement of opioid system in cognitive deficits induced by-tetrahydrocannabinol in rats. Psychopharmacology (Berlin) 2012, 219:1111-1118.
23. Egertova M., Giang D.K., Cravatt B.F., Elphick M.R. A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proceedings of the Royal Society of London Series B - Biological Sciences 1998, 265:2081-2085.
24. Fernandez-Ruiz J., Berrendero F., Hernandez M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends in Neurosciences 2000, 23:14-20.
25. Fernandez-Ruiz J.J., Berrendero F., Hernandez M.L., Romero J., Ramos J.A. Role of endocannabinoids in brain development. Life Sciences 1999, 65:725-736.
26. Ferrari F., Ottani A., Vivoli R., Giuliani D. Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task. Pharmacology, Biochemistry and Behavior 1999, 64:555-561.
27. Foldy C., Neu A., Jones M.V., Soltesz I. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. Journal of Neuroscience 2006, 26:1465-1469.
28. Fornari R.V., Wichmann R., Atucha E., Desprez T., Eggens-Meijer E., Roozendaal B. Involvement of the insular cortex in regulating glucocorticoid effects on memory consolidation of inhibitory avoidance training. Frontiers in Behavioral Neuroscience 2012, 6:10.
29. Freund T.F., Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996, 6:347-470.
30. A, receptor agonists in adult rats. Neurotoxicology and Teratology 1999, 21:277-283.
31. Gerdeman G., Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. Journal of Neurophysiology 2001, 85:468-471.
32. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., et al. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Research 2006, 1071:10-23.
33. Hajos N., Freund T.F. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chemistry and Physics of Lipids 2002, 121:73-82.
34. Hajos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. European Journal of Neuroscience 2000, 12:3239-3249.
35. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009, 374:1383-1391.
36. Hampson R.E., Deadwyler S.A. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. Journal of Neuroscience 2000, 20:8932-8942.
37. 9-tetrahydrocannabinol in humans. Psychopharmacology (Berlin) 2002, 164:407-415.
38. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience 1991, 11:563-583.
39. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., et al. Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:1932-1936.
40. Heyser C.J., Hampson R.E., Deadwyler S.A. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: Alterations in short-term memory associated with changes in task specific firing of hippocampal cells. Journal of Pharmacology and Experimental Therapeutics 1993, 264:294-307.
41. A synaptic transmission in the hippocampus. Journal of Neuroscience 2000, 20:2470-2479.
42. Hoffman A.F., Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: A comparison with opioids. Journal of Neurophysiology 2001, 85:72-83.
43. Hoffman A.F., Riegel A.C., Lupica C.R. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. European Journal of Neuroscience 2003, 18:524-534.
44. Izquierdo I., da Cunha C., Rosat R., Jerusalinsky D., Ferreira M.B., Medina J.H. Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. Behavioral and Neural Biology 1992, 58:16-26.
45. Izquierdo I., Medina J.H. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiology of Learning and Memory 1995, 63:19-32.
46. Jamali-Raeufy N., Nasehi M., Zarrindast M.R. Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus. Behavioural Pharmacology 2011, 22:645-654.
47. Katona I., Sperlagh B., Magloczky Z., Santha E., Kofalvi A., Czirjak S., et al. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 2000, 100:797-804.
48. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. Journal of Neuroscience 1999, 19:4544-4558.
49. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., et al. Molecular composition of the endocannabinoid system at glutamatergic synapses. Journal of Neuroscience 2006, 26:5628-5637.
50. Knowles W.D. Normal anatomy and neurophysiology of the hippocampal formation. Journal of Clinical Neurophysiology 1992, 9:252-263.
51. Laaris N., Good C.H., Lupica C.R. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology 2010, 59:121-127.
52. Lamprecht R., LeDoux J. Structural plasticity and memory. Nature Reviews Neuroscience 2004, 5:45-54.
53. Levenes C., Daniel H., Soubrie P., Crepel F. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. Journal of Physiology 1998, 510(Pt 3):867-879.
54. Lichtman A.H. SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. European Journal of Pharmacology 2000, 404:175-179.
55. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berlin) 1995, 119:282-290.
56. Ling D.S., Benardo L.S. Properties of isolated GABAB-mediated inhibitory postsynaptic currents in hippocampal pyramidal cells. Neuroscience 1994, 63:937-944.
57. Luzi S., Morrison P.D., Powell J., di Forti M., Murray R.M. What is the mechanism whereby cannabis use increases risk of psychosis?. Neurotoxicity Research 2008, 14:105-112.
58. Mackie K. Cannabinoid receptors as therapeutic targets. Annual Review of Pharmacology and Toxicology 2006, 46:101-122.
59. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. Journal of Neuroscience 1995, 15:6552-6561.
60. Mackie K., Stella N. Cannabinoid receptores and endocannabinoids: Evidence for new players. The AAPS 2006, 8:298-306.
61. Mackowiak M., Chocyk A., Dudys D., Wedzony K. Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience 2009, 158:1708-1716.
62. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience 1999, 11:4213-4225.
63. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
64. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
65. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 1995, 50:83-90.
66. Molina-Holgado F., Amaro A., Gonzalez M.I., Alvarez F.J., Leret M.L. Effect of maternal delta 9-tetrahydrocannabinol on developing serotonergic system. European Journal of Pharmacology 1996, 316:39-42.
67. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 2007, 370:319-328.
68. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
69. Naderi N., Haghparast A., Saber-Tehrani A., Rezaii N., Alizadeh A.M., Khani A., et al. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice. Pharmacology, Biochemistry and Behavior 2008, 89:64-75.
70. Nahas G., Latour C. The human toxicity of marijuana. Medical Journal of Australia 1992, 156:495-497.
71. Nasehi M., Sahebgharani M., Haeri-Rohani A., Zarrindast M.R. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiology of Learning and Memory 2009, 92:391-399.
72. Nguyen P.V., Abel T., Kandel E.R. Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994, 265:1104-1107.
73. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
74. O'Keefe J. Hippocampus, theta, and spatial memory. Current Opinion in Neurobiology 1993, 3:917-924.
75. Paulsen O., Moser E.I. A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends in Neurosciences 1998, 21:273-278.
76. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press. 2nd ed.
77. Pertwee R.G., Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukotrienes and Essential Fatty Acids 2002, 66:101-121.
78. Pettit D.A., Harrison M.P., Olson J.M., Spencer R.F., Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. Journal of Neuroscience Research 1998, 51:391-402.
79. Ranganathan M., D'Souza D.C. The acute effects of cannabinoids on memory in humans: A review. Psychopharmacology (Berlin) 2006, 188:425-444.
80. Robbe D., Alonso G., Duchamp F., Bockaert J., Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. Journal of Neuroscience 2001, 21:109-116.
81. Robbe D., Montgomery S.M., Thome A., Rueda-Orozco P.E., McNaughton B.L., Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nature Neuroscience 2006, 9:1526-1533.
82. Robinson L., McKillop-Smith S., Ross N.L., Pertwee R.G., Hampson R.E., Platt B., et al. Hippocampal endocannabinoids inhibit spatial learning and limit spatial memory in rats. Psychopharmacology (Berlin) 2008, 198:551-563.
83. Roullet P., Mele A., Ammassari-Teule M. Involvement of glutamatergic and dopaminergic systems in the reactivity of mice to spatial and non-spatial change. Psychopharmacology (Berlin) 1996, 126:55-61.
84. Roullet P., Sargolini F., Oliverio A., Mele A. NMDA and AMPA antagonist infusions into the ventral striatum impair different steps of spatial information processing in a nonassociative task in mice. Journal of Neuroscience 2001, 21:2143-2149.
85. Rubino T., Parolaro D. Long lasting consequences of cannabis exposure in adolescence. Molecular and Cellular Endocrinology 2008, 286:S108-S113.
86. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., et al. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 2007, 152:1092-1101.
87. Schlicker E., Timm J., Gothert M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch Pharmacol 1996, 354:791-795.
88. Schmidt K., Krishnan B., Xia Y., Sun A., Orozco-Cabal L., Pollandt S., et al. Cocaine withdrawal reduces group I mGluR-mediated long-term potentiation via decreased GABAergic transmission in the amygdala. European Journal of Neuroscience 2011, 34:177-189.
89. Solis J.M., Nicoll R.A. Pharmacological characterization of GABAB-mediated responses in the CA1 region of the rat hippocampal slice. Journal of Neuroscience 1992, 12:3466-3472.
90. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
91. Stiglick A., Kalant H. Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats. Psychopharmacology (Berl) 1982, 77:117-123.
92. Sullivan J.M. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. Journal of Neurophysiology 1999, 82:1286-1294.
93. Sun N., Laviolette S.R. Inactivation of the basolateral amygdala during opiate reward learning disinhibits prelimbic cortical neurons and modulates associative memory extinction. Psychopharmacology (Berlin) 2012, 222:645-661.
94. Takahashi R.N., Pamplona F.A., Fernandes M.S. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neuroscience Letters 2005, 380:270-275.
95. 1 receptor results in differential effects on 'non-associative' memory and forebrain monoamine concentrations in mice. Neurobiology of Learning and Memory 2007, 88:416-423.
96. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
97. Tsou K., Mackie K., Sanudo-Pena M.C., Walker J.M. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 1999, 93:969-975.
98. Varvel S.A., Hamm R.J., Martin B.R., Lichtman A.H. Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology (Berlin) 2001, 157:142-150.
99. Varvel S.A., Lichtman A.H. Evaluation of CB1 receptor knockout mice in the Morris water maze. Journal of Pharmacology and Experimental Therapeutics 2002, 301:915-924.
100. Vela G., Fuentes J.A., Bonnin A., Fernandez-Ruiz J., Ruiz-Gayo M. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Research 1995, 680:142-147.
101. Vela G., Martin S., Garcia-Gil L., Crespo J.A., Ruiz-Gayo M., Javier Fernandez-Ruiz J., et al. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Research 1998, 807:101-109.
102. A receptor density is altered by cannabinoid treatment in the hippocampus of adult but not adolescent rats. Brain Research 2010, 1351:238-245.
103. Viveros M.P., Llorente R., Moreno E., Marco E.M. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behavioural Pharmacology 2005, 16:353-362.
104. Viveros M.P., Marco E.M., File S.E. Endocannabinoid system and stress and anxiety responses. Pharmacology, Biochemistry and Behavior 2005, 81:331-342.
105. Werling L.L., Reed S.C., Wade D., Izenwasser S. Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats. International Journal of Developmental Neuroscience 2009, 27:263-269.
106. Wiley J.L., Evans R.L., Grainger D.B., Nicholson K.L. Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug. Pharmacological Reports 2011, 63:1085-1092.
107. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science 2002, 296:678-682.
108. 1 receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task. European Journal of Pharmacology 2008, 590:246-249.
109. 9-tetrahydrocannabinol. Neuropsychopharmacology 2009, 34:2072-2080.
110. Yim T.T., Hong N.S., Ejaredar M., McKenna J.E., McDonald R.J. Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus. Neuroscience 2008, 151:929-936.
111. Zarrindast M.R., Mahboobi S., Sadat-Shirazi M.S., Ahmadi S. Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems. Journal of Psychopharmacology 2011, 25:131-140.
112. Zarrindast M.R., Nasehi M., Piri M., Bina P. Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected into the dorsal hippocampus in mice. Pharmacology, Biochemistry and Behavior 2010, 94:387-396.
113. Zarrindast M.R., Navaeian M., Nasehi M. Influence of three-day morphine-treatment upon impairment of memory consolidation induced by cannabinoid infused into the dorsal hippocampus in rats. Neuroscience Research 2010, 69:51-59.